Discover how SYK (spleen tyrosine kinase) acts as a master cellular switch driving multiple myeloma progression and treatment resistance through bioinformatics analysis.
Exploring the central role of Junctional Adhesion Molecule-a (JAM-a) in multiple myeloma patients with extramedullary disease
Discover how bioinformatics analysis identifies prognostic biomarkers in high-risk multiple myeloma through Gene Expression Omnibus database mining.
Exploring how epigenetic regulation in chronic lymphocytic leukemia and multiple myeloma reveals new therapeutic opportunities.